Identification of Glypican-3 as a potential metastasis suppressor gene in gastric cancer

被引:30
|
作者
Han, Shiwei [1 ,2 ,3 ,4 ]
Ma, Xuemei [1 ,3 ,4 ]
Zhao, Yanxia [5 ]
Zhao, Hongying [6 ]
Batista, Ana [2 ]
Zhou, Sheng [7 ]
Zhou, Xiaona [1 ,3 ,4 ]
Yang, Yao [1 ,3 ,4 ]
Wang, Tingting [1 ,3 ,4 ]
Bi, Jingtao [8 ]
Xia, Zheng [9 ]
Bai, Zhigang [1 ,3 ,4 ]
Garkavtsev, Igor [2 ]
Zhang, Zhongtao [1 ,3 ,4 ]
机构
[1] Capital Med Univ, Beijing Friendship Hosp, Dept Gen Surg, Beijing, Peoples R China
[2] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA
[3] Beijing Key Lab Canc Invas & Metastasis Res, Beijing, Peoples R China
[4] Natl Clin Res Ctr Digest Dis, Beijing, Peoples R China
[5] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Ctr Canc, Wuhan, Peoples R China
[6] Capital Med Univ, Beijing Chaoyang Hosp, Dept Pathol, Beijing, Peoples R China
[7] Huazhong Univ Sci & Technol, Inst Pathol, Union Hosp, Tongji Med Coll, Wuhan, Peoples R China
[8] Peking Univ, Dept Gen Surg, Beijing Jishuitan Hosp, Med Coll 4, Beijing, Peoples R China
[9] Cent S Univ, Dept Surg, Xiangya Hosp, Changsha, Hunan, Peoples R China
基金
中国国家自然科学基金;
关键词
gastric cancer; Glypican-3; metastasis; FoxM1; Erk1/2; GOLABI-BEHMEL-SYNDROME; FOXM1; OVERGROWTH; EXPRESSION; PATHWAYS; THERAPY; KINASE; TARGET; TUMORS; CELLS;
D O I
10.18632/oncotarget.9763
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Gastric cancer is a prevalent tumor that is usually detected at an advanced metastatic stage. Currently, standard therapies are mostly ineffective. Here, we report that Glypican-3 (GPC3) is absent in invasive tumors and metastatic lymph nodes, in particular in aggressive and highly disseminated signet ring cell carcinomas. We demonstrate that loss of GPC3 correlates with poor overall survival in patients. Moreover, we show that absence of GPC3 causes up-regulation of MAPK/FoxM1 signaling and that blockade of this pathway alters cellular invasion. An inverse correlation between GPC3 and FoxM1 is also shown in patient samples. These data identify GPC3 as a potential metastasis suppressor gene and suggest its value as a prognostic marker in gastric cancer. Development of therapies targeting signaling downstream of GPC3 are warranted.
引用
收藏
页码:44406 / 44416
页数:11
相关论文
共 50 条
  • [31] Glypican-5 is a novel metastasis suppressor gene in non-small cell lung cancer
    Yang, Xin
    Zhang, Zhi
    Qiu, Mantang
    Hu, Jingwen
    Fan, Xiaohu
    Wang, Jie
    Xu, Lin
    Yin, Rong
    CANCER LETTERS, 2013, 341 (02) : 265 - 273
  • [32] GLYPICAN-3 ENRICHED IN EXOSOMES NOT IN THE MICROVESICLES: A POTENTIAL BIOMARKER FOR HEPATOCELLULAR CARCINOMA
    Koksal, Ali Riza
    Aydin, Yucel
    Lin, Dong
    Nunez, Kelley
    Thevenot, Paul
    Parsi, Mansour A.
    Cohen, Ari J.
    Dash, Srikanta
    HEPATOLOGY, 2021, 74 : 691A - 692A
  • [33] Glypican-3 is involved in cellular protection against mitoxantrone in gastric carcinoma cells
    Anke Wichert
    Alexandra Stege
    Yutaka Midorikawa
    Per Sonne Holm
    Hermann Lage
    Oncogene, 2004, 23 : 945 - 955
  • [34] Glypican-3 is involved in cellular protection against mitoxantrone in gastric carcinoma cells
    Wichert, A
    Stege, A
    Midorikawa, Y
    Holm, PS
    Lage, H
    ONCOGENE, 2004, 23 (04) : 945 - 955
  • [35] GLYPICAN-3 PROMOTES HEPATOCELLULAR CARCINOMA PROGRESSION AND METASTASIS BY ACTIVATION OF THE ERK SIGNALING PATHWAY
    Wu, Y.
    Liu, H.
    Weng, H.
    Zhang, X.
    Li, P.
    Fan, C.
    Li, B.
    Dong, P.
    Li, L.
    Dooley, S.
    Ding, H.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S429 - S430
  • [36] TXNIP is a potential tumor suppressor gene in gastric cancer cells
    Tang, Angie
    So, K.
    Leung, P.
    Tong, H.
    Ko, B.
    To, K.
    CANCER RESEARCH, 2009, 69
  • [37] Advances in Liver Cancer Antibody TherapiesA Focus on Glypican-3 and Mesothelin
    Mitchell Ho
    BioDrugs, 2011, 25 : 275 - 284
  • [38] Significance of Glypican-3 (GPC3) Expression in Hepatocellular Cancer Diagnosis
    Sun, Bin
    Huang, Zhi
    Wang, Bi
    Yu, Yanglong
    Lin, Shihai
    Luo, Lei
    Wang, Yuzhu
    Huang, Zheng
    MEDICAL SCIENCE MONITOR, 2017, 23 : 850 - 855
  • [39] Development of Glypican-3 Targeting Immunotoxins for the Treatment of Liver Cancer: An Update
    Fleming, Bryan D.
    Ho, Mitchell
    BIOMOLECULES, 2020, 10 (06) : 1 - 16
  • [40] The Role of Glypican-3 in Regulating Wnt, YAP, and Hedgehog in Liver Cancer
    Kolluri, Aarti
    Ho, Mitchell
    FRONTIERS IN ONCOLOGY, 2019, 9